To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Cartilage Repair Market size was valued at USD 1.46 Billion in 2024 and is poised to grow from USD 1.71 Billion in 2025 to USD 6 Billion by 2033, growing at a CAGR of 17% during the forecast period 17%.

    The cartilage repair market is highly competitive and has matured firms as well as new biotech firms. The smaller businesses have been focusing on advanced regenerative medicines, such as tissue engineering and stem cell-based therapies. Growth strategies through strategic alliances, mergers, and ongoing research and development form the majority dynamics for the market.  'DePuy Synthes (Johnson & Johnson) ', 'Zimmer Biomet Holdings Inc. ', 'Smith & Nephew plc ', 'Vericel Corporation ', 'Osiris Therapeutics Inc. ', 'Histogenics Corporation ', 'Anika Therapeutics Inc ', 'Arthrex Inc. ', 'B. Braun Melsungen AG ', 'Stryker Corporation ', 'CONMED Corporation ', 'Orthocell Limited ', 'RTI Surgical Holdings Inc. ', 'MEDIPOST Co. Ltd. ', 'CellGenix GmbH ', 'Tissue Regenix Group plc ', 'CollPlant Biotechnologies Ltd. ', 'ISTO Technologies Inc. ', 'MTF Biologics ', 'CartiHeal Ltd.'

    The most common patients requiring knee cartilage repair surgery are young people who have suffered injuries in the knee joint, such as meniscal or ligament tears. Damaged cartilage is repaired using methods that include cell-based cartilage resurfacing and autologous chondrocyte implantation to hasten the formation of new cartilage in joints. It delays and prevents the occurrence of arthritis, which also greatly reduces joint pain and increases joint flexibility through repairing and replacing the cartilage. 

    Minimally Invasive Techniques: More and more, patients seek therapies that allow rapid recovery, less morbidity, and less pain after surgery. The success of restoring cartilage effectively with fewer incisions and rapid recovery is what appeals to procedures such as arthroscopy, biologic injections (PRP, stem cells), and microfracture surgery. Those techniques will eventually supplant more invasive and traditional operations as they continue to evolve. 

    In 2023, North America was established as the market leader, commanding a share of over 45%. If people choose a healthy lifestyle, the forecast till at least the end of the review period is for the region to maintain its leading position. The urge for and appeal of cartilage repair in the United States and Canada is largely driven by a target audience and shifts in lifestyles, combined with the ever-increasing rate of musculoskeletal disorders. Further, the incidence of osteoporosis in the UK, Germany, and France is increasing significantly, and about 500,000 people require hospital care each year due to fractures at standing height or below caused by osteoporosis. It is expected to affect the Europe market. 

    Feedback From Our Clients

    Global Cartilage repair market

    Report ID: SQMIG35D2072

    $5,300
    BUY NOW